You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Renal cell carcinoma (RCC)

Showing 76 - 100 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Renal Cell, Renal Cell Carcinoma of Papillary Histology, Renal Cell Carcinoma With Clear Cell Histology Trial in

Completed
  • Carcinoma, Renal Cell
  • +3 more
  • Ann Arbor, Michigan
  • +8 more
Dec 16, 2020

Japanese RCC Patients Treated With Avelumab Plus Axitinib as

Completed
  • Renal Cell Carcinoma
  • Kurume, Fukuoka, Japan
  • +11 more
Feb 22, 2022

Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

Not yet recruiting
  • Papillary Renal Cell Carcinoma
  • (no location specified)
Nov 24, 2023

Renal Cancers Trial in Dallas (Stereotactic Ablative Radiation Therapy)

Active, not recruiting
  • Renal Cancers
  • Stereotactic Ablative Radiation Therapy
  • Dallas, Texas
    University of Texas Southwestern
Oct 21, 2021

(PRO) Registry in Patients With Advanced Renal Cell Carcinoma

Completed
  • Renal Cell Carcinoma
    • Multiple Locations, Germany
      Multiple sites all over Germany
    Mar 24, 2021

    Renal Cell Carcinoma Trial in Tabriz (Sodium Pentaborate)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Sodium Pentaborate
    • Tabriz, East Azarbayejan, Iran, Islamic Republic of
      Imam Reza hospital and Clinic of Salamat
    Mar 23, 2023

    Clear Cell Renal Cell Carcinoma Trial in United States (Placebo, CB-839, everolimus)

    Completed
    • Clear Cell Renal Cell Carcinoma
    • Placebo
    • +2 more
    • Tucson, Arizona
    • +37 more
    Aug 16, 2021

    Develop Circulating Exosomes as Predictive Biomarkers for

    Recruiting
    • Renal Cell Carcinoma
    • Other: Blood and Urine Collection
    • Hangzhou, China
      An Zhao
    Jan 30, 2023

    Moesin Expression in Clear Cell Renal Cell Carcinoma

    Completed
    • Renal Cell Carcinoma
    • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
    • (no location specified)
    Sep 20, 2023

    Renal Cell Carcinoma Trial (Pembrolizumab)

    Completed
    Has Results
    • Renal Cell Carcinoma
    • Pembrolizumab
    • (no location specified)
    Aug 17, 2022

    Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, MK-4830, Belzutifan)

    Recruiting
    • Carcinoma, Renal Cell
    • Pembrolizumab
    • +5 more
    • New Haven, Connecticut
    • +38 more
    Jan 25, 2023

    Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan)

    Recruiting
    • Carcinoma, Renal Cell
    • Pembrolizumab
    • +5 more
    • New Haven, Connecticut
    • +37 more
    Jan 25, 2023

    Renal Cancer Trial in Aarhus N

    Enrolling by invitation
    • Renal Cancer
      • Aarhus N, Denmark
        Urology Department Aarhus University Hospital
      Nov 21, 2023

      Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma Trial (BGB-A445, Tislelizumab)

      Not yet recruiting
      • Urothelial Carcinoma
      • +2 more
      • (no location specified)
      Dec 15, 2022

      Spanish Real-World Evidence Cabozantinib

      Recruiting
      • Renal Cell Carcinoma
      • Córdoba, Andalucía, Spain
      • +31 more
      Sep 21, 2021

      Renal Cell Carcinoma Trial in Worldwide (Atezolizumab, Bevacizumab, RO6874281)

      Completed
      • Renal Cell Carcinoma
      • New Haven, Connecticut
      • +22 more
      Sep 10, 2021

      Expanded Genome-Wide Association Study of Renal Cell Carcinoma

      Completed
      • Kidney Cancer
      • Intervention in the UroCCR sites
      • +3 more
      • Talence, France
        Centre Hospitalier Universitaire de Bordeaux
      Jul 10, 2020

      Metastatic Renal Cell Carcinoma Trial in Worldwide (Ipilimumab plus nivolumab, Standard Therapy)

      Recruiting
      • Metastatic Renal Cell Carcinoma
      • Ipilimumab plus nivolumab
      • Standard Therapy
      • Gent, Belgium
      • +40 more
      Feb 7, 2022

      Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)

      Completed
      • Colorectal Cancer (CRC)
      • +10 more
      • San Francisco, California
      • +16 more
      Mar 30, 2022

      Renal Cell Carcinoma, Neoadjuvant Trial (Axitinib plus Toripalimab, radical nephrectomy)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Neoadjuvant
      • Axitinib plus Toripalimab
      • radical nephrectomy
      • (no location specified)
      Feb 12, 2023

      Metastatic sRCC Trial in Philadelphia (Avelumab, Gemcitabine)

      Recruiting
      • Metastatic sRCC
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Jul 22, 2021

      Cabozantinib in Advanced Renal Cell Carcinoma (RCC) in UK

      Completed
      • Advanced Renal Cell Carcinoma
        • Brighton, United Kingdom
        • +5 more
        Nov 4, 2020

        Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

        Not yet recruiting
        • Renal Cell Carcinoma
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 11, 2022

        Renal Cell Carcinoma Trial in Rome (donor FMT, Placebo FMT)

        Recruiting
        • Renal Cell Carcinoma
        • donor FMT
        • Placebo FMT
        • Rome, Italy
        • +1 more
        Jul 26, 2022

        Renal Cell Carcinoma Trial (Cytoreductive Nephrectomy)

        Not yet recruiting
        • Renal Cell Carcinoma
        • Cytoreductive Nephrectomy
        • (no location specified)
        Jul 3, 2023